Clinical trial
68Ga-PSMA-11 PET/CT for Staging of Intermediate and High Risk Prostate Cancer Prior to Radical Prostatectomy
NCT03368547 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 68Ga-PSMA-11 PET/CT for Staging of Intermediate and High Risk Prostate Cancer Prior to Radical Prostatectomy
- Lead sponsor
- Jonsson Comprehensive Cancer Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 12, 2016
- Completion date
- June 18, 2021
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate adenocarcinoma, stage iib prostate cancer ajcc v7, stage iii prostate cancer ajcc v7, stage iv prostate cancer ajcc v7